- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05720884
Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy (ASBP)
Efficacy and Safety of Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy: a Randomized Controlled, Parallel-grouped Pilot Study
The goal of this pilot clinical trial is to learn about efficacy of acupuncture about blood pressure fluctuation during total laparoscopic hysterectomy in patients with uterine fibroid.
Participants will receive two times of acupuncture treatment before surgery and researchers will compare to see if acupuncture treatment would stabilize blood pressure fluctuation especially from induction time to post-incision moment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After sufficient explanation about the purpose and methods of this clinical study by a researcher, the subject who voluntarily decided to participate and signed a written consent will be evaluated for eligibility at the screening visit. Eligible subjects will be determined as acupuncture group and a placebo control group according to the randomization. Acupuncture treatment is performed twice, one day before surgery and the same day.
On the day of surgery, after entering the operating room, monitoring equipments (non-invasive blood pressure monitor, pulse oxygen saturation, electrocardiogram, anesthesia depth sensor, neuromuscular monitor) will be installed and vital signs including pulse rate, blood pressure, oxygen saturation are measured.
Anesthesia was induced with an anesthetic (intravenous propofol 1-2.5 mg/kg, IV), an analgesic (remifentanyl 0.2mg/hr, IVF), and a muscle relaxant (intravenous rocuronium 0.6-1.2 mg/kg). After induction of anesthesia, anesthesiologist performed tracheal intubation maintaining an appropriate depth of anesthesia (Sedline < 50). Mechanical ventilation started keeping end-tidal CO2 pressure of 25-35 mmHg). Then, an additional venous tube was secured. Additional disinfection process was performed, surgery is prepared.
With the patient in the lithotomy position and under the general anesthesia, the abdomen was prepared, painted and draped with the usual manner. The uterine elevator was inserted. Skin incision was performed and trocar was inserted. The CO2 gas was infused to make pneumoperitoneum which pressure was reached to 12mmHg. Entering into the abdominal cavity, the patient position was changed to the Trendelenburg position. And then the pelvic cavity and whole abdomen were examined. Bilateral pelvic side wall triangles were opened in parallel to infundibulopelvic ligament and ureter dissection was done. The ureteral course was identified, and then the right round ligament and ovarian ligament were coagulated with bipolar endocoagulator, cut with endoscissors. The left sided uterine ligaments were manipulated with the same method as above. The bladder flap was pushed and posterior broad ligament was mobilized. Bilateral uterine vessels were skeletonized and bilateral uterine vessels were coagulated and then cut. Circumferential colpotomy was done with unipolar scissor, and the uterus was removed transvaginally and then vaginal cuff was closed intracorporeal continuous suture. Hemostasis and ureteral peristalsis were assured and abdominal cavity was irrigated with normal saline. The subcutaneous tissue and the skin were closed layer by layer. In all processes, a qualified anesthesiologist whose clinical experience of more than 10 years will control the analgesic or anesthetic injection rate and inhalation gas concentration to maintain the appropriate blood pressure and depth of anesthesia.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jee Young Lee, Dr
- Phone Number: 082-31-782-3113
- Email: happiade@chamc.co.kr
Study Locations
-
-
Gyeonggi-do
-
Goyang-si, Gyeonggi-do, Korea, Republic of, 10414
- Recruiting
- Lee Jee Young
-
Contact:
- Jee Young Lee, Dr
- Phone Number: 082-31-782-3113
- Email: happiade@chamc.co.kr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Adulthood participants who were planned to have surgical removal of uterus for uterine fibroid and have expected date of total laparoscopic hysterectomy by a gynecologist were eligible.
Inclusion criteria
- between age of 19 and 69,
- American Society of Anesthesiologists (ASA) class I or II,
- required surgical removal of uterus by a gynecology specialist,
- scheduled to have total laparoscopic hysterectomy in advance.
Exclusion criteria
- expected survival within 3 months,
- emergency operation which was not scheduled in advance,
- hypertension or hypotension that can significantly interfere with the study result,
- diagnosis of arrhythmia, such as atrial fibrillation, frequent ventricular or supraventricular premature beats,
- diagnosis of heart failure or valvular disease,
- anemia of hemoglobin < 12 g/dL,
- incapable of surgery due to hemodynamic or medical reasons other than stated above,
- incapable of receiving acupuncture treatment on determined location,
- current use of gonadotropin-releasing hormone receptor agonists,
- current use of drugs that may interfere with the result, including steroids, immunosuppressants, and psychiatric disorders,
- significant comorbidities that may interfere with the interpretation of intervention efficacy or results, such as stroke, myocardial infarction, kidney disease, dementia, or epilepsy,
- pregnant, planning to be pregnant within study period, or breastfeeding,
- previous participation in any other clinical trial within 1 month of participation, planning to participate another clinical trial within 6 months after enrollment date, or planning to participate another clinical trial on follow-up period,
- fail to write the informed consent form voluntarily,
- being deemed to be unsuitable for participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: acupuncture group
A total 10 acupoints of bilateral PC6, PC5, SP3, KI3, and ST36 will be chosen for the intervention group, also known as the acupuncture group.
The depth of acupuncture will be varied by participant by participant.
After acupuncture needles be inserted, the needles will be manually manipulated to obtain pre-determined sensation, the De Qi.
Then, acupuncture will remain inserted for 20 minutes.
|
Acupuncture of a disposable, sterilized, stainless steel needle of 0.20 mm * 30 mm size (Dongbang medical, Boryeong, Rep of Korea) will be used.
|
Placebo Comparator: placebo group
Ten other points, which are not official acupoints and those are not on the median nerve or peroneal nerve, will be chosen for the placebo group.
|
Acupuncture of a disposable, sterilized, stainless steel needle of 0.20 mm * 30 mm size (Dongbang medical, Boryeong, Rep of Korea) will be used but in differene location.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes in mean blood pressure
Time Frame: At operation time
|
the difference between the highest mean blood pressure and the lowest mean blood pressure from the induction of anesthesia to the post-incision period
|
At operation time
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blood pressures according to predetermined timepoints
Time Frame: At operation time
|
systolic blood pressure, diastolic blood pressure and mean blood pressure values at entering operation room, induction time, intubation time, venous tube insertion, preparation time, skin incision, and gas inflation.
|
At operation time
|
incidence of hypotension
Time Frame: At the end of operation moment
|
Total incidence count of hypotension events, determined as lower than 80% of baseline or systolic blood pressure below 90
|
At the end of operation moment
|
incidence of hypertension
Time Frame: At the end of operation moment
|
Total incidence count of hypertension events, determined as systolic blood pressure over 160
|
At the end of operation moment
|
incidence of tachycardia according to predetermined timepoints
Time Frame: At the end of operation moment
|
heart rate values at entering operation room, induction time, intubation time, venous tube insertion, preparation time, skin incision, and gas inflation.
|
At the end of operation moment
|
incidence of bradycardia according to predetermined timepoints
Time Frame: At the end of operation moment
|
heart rate values at entering operation room, induction time, intubation time, venous tube insertion, preparation time, skin incision, and gas inflation.
|
At the end of operation moment
|
total use of remifentanil
Time Frame: At the end of operation moment
|
Use of remifentanil dosage will be surrogate markers of stable general anesthesia.
|
At the end of operation moment
|
numeric rating scale for pain
Time Frame: before operation(operation date), at the end of operation moment
|
numeric rating scale is a 11 point scale that defined point 0 as totally painless state, and point 10 as extreme pain as imaginable as possible.
|
before operation(operation date), at the end of operation moment
|
Spielberger's State-Trait Anxiety Inventory (STAI)
Time Frame: before operation(operation date), at the end of operation moment
|
State-Trait Anxiety Inventory (STAI) consists of two categories, twenty items of questionnaire to assess state anxiety (STAI-S) and another twenty items to assess trait anxiety (STAI-T).
STAI varies from a minimum score of 20 to a maximum score of 80. Lower scores means presence of less anxiety (no or low anxiety 20-37, moderate 38-44, and high anxiety 45-80).
|
before operation(operation date), at the end of operation moment
|
EuroQoL-5 Dimensions - 5 Levels (EQ-5D-5L)
Time Frame: before operation(operation date), at the end of operation moment
|
The EQ-5D-5L is used to assess effects on patients' quality of life.
The questionnaire consists of questions in five areas (mobility, self-care, usual activities, pain, and anxiety/depression) that ask about the patient's current state of health.
Answers are provided on a 5-point Likert scale.
|
before operation(operation date), at the end of operation moment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jee Young Lee, Dr, Cha Ilsan Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ICICC-CT-22-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Laparoscopic Hysterectomy
-
Mansoura UniversityRecruitingTotal Laparoscopic HysterectomyEgypt
-
ZSX Medical LLCCompletedTotal Laparoscopic HysterectomyMexico
-
Ain Shams Maternity HospitalRecruitingTotal Laparoscopic HysterectomyEgypt
-
Istanbul UniversityUniversity of SurreyCompletedTotal Laparoscopic Hysterectomy | Benign ConditionsTurkey
-
Yonsei UniversityCompletedPatients Undergoing Total Laparoscopic HysterectomyKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterCompletedGynecologic Condition | Scheduled for a Total Laparoscopic or Robotic-assisted HysterectomyUnited States
-
Gaziosmanpasa Research and Education HospitalCompletedInflammation | Total Laparoscopic Hysterectomy | Hospital Stay
-
ZSX Medical LLCTerminatedLaparoscopic HysterectomyUnited States
-
University of North Carolina, Chapel HillCompletedLaparoscopic HysterectomyUnited States
-
Balikesir UniversityCompleted
Clinical Trials on acupuncture
-
Federal University of São PauloCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
Huazhong University of Science and TechnologyThe University of Hong Kong; Heilongjiang University of Chinese Medicine; Hubei...CompletedPolycystic Ovary SyndromeChina
-
China Medical University HospitalNot yet recruiting